Skip to main content

Table 2 Correlation between clinicopathological features and expression of TAZ in retinoblastoma patients

From: High expression of TAZ indicates a poor prognosis in retinoblastoma

Feature All patients n = 43, n (%) Expression of TAZ P value
High Low
Age at presentation (y)   28 15 0.602
  < 5 y 39 (90.7) 26 13  
  ≥ 5 y 4 (9.3) 2 2  
Gender   28 15 0.338
 Male 18 (41.9) 10 8  
 Female 25 (58.1) 18 7  
Tumor enucleated location   28 15 1.000
 Right 25 (58.1) 16 9  
 Left 18 (41.9) 12 6  
cTNM classification  
T classification   28 15 0.116
 T1 + 2 24 13 11  
 T3 + 4 19 15 4  
N classification   28 15 0.013*
 N0 20 9 11  
 N1 + 2 23 19 4  
cTNM stage   28 15 0.184
 I + II 14 7 7  
 III + IV 29 21 8  
Largest tumor base (mm)   28 15 0.045*
  ≤ 15 mm 28 (65.1) 15 13  
  > 15 mm 15 (34.9) 13 2  
Tumor thickness (mm)   28 15 0.750
  ≤ 10 mm 25 (58.1) 17 8  
  > 10 mm 18 (41.9) 11 7  
Differentiation   28 15 0.019*
 Well and moderate 24 (55.8) 12 12  
 Poorly 19 (44.2) 16 3  
  1. *P < 0.05